Singapore markets closed
Straits Times Index
3,176.51 -11.15 (-0.35%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,224.14 -161.73 (-0.99%) FTSE 100
7,895.85 +18.80 (+0.24%) Bitcoin USD
64,084.40 +623.91 (+0.98%) CMC Crypto 200
1,385.36 +72.74 (+5.54%)
Clover Health Investments, Corp. (CLOV)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 312.03M |
| Enterprise value | 74.01M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 0.15 |
| Price/book (mrq) | 1.09 |
| Enterprise value/revenue | 0.04 |
| Enterprise value/EBITDA | -0.35 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.85 |
| 52-week change 3 | -19.31% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 1.6300 |
| 52-week low 3 | 0.6100 |
| 50-day moving average 3 | 0.8233 |
| 200-day moving average 3 | 1.0064 |
Share statistics
| Avg vol (3-month) 3 | 9.46M |
| Avg vol (10-day) 3 | 7.12M |
| Shares outstanding 5 | 405.64M |
| Implied shares outstanding 6 | 503.22M |
| Float 8 | 375.12M |
| % held by insiders 1 | 7.38% |
| % held by institutions 1 | 24.48% |
| Shares short (28 Mar 2024) 4 | 43.98M |
| Short ratio (28 Mar 2024) 4 | 3.23 |
| Short % of float (28 Mar 2024) 4 | 10.91% |
| Short % of shares outstanding (28 Mar 2024) 4 | 8.88% |
| Shares short (prior month 29 Feb 2024) 4 | 36.54M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -10.48% |
| Operating margin (ttm) | -10.35% |
Management effectiveness
| Return on assets (ttm) | -16.98% |
| Return on equity (ttm) | -66.33% |
Income statement
| Revenue (ttm) | 2.04B |
| Revenue per share (ttm) | 4.22 |
| Quarterly revenue growth (yoy) | -44.30% |
| Gross profit (ttm) | N/A |
| EBITDA | -186.08M |
| Net income avi to common (ttm) | -213.36M |
| Diluted EPS (ttm) | -0.4400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 242.68M |
| Total cash per share (mrq) | 0.49 |
| Total debt (mrq) | 4.66M |
| Total debt/equity (mrq) | 1.63% |
| Current ratio (mrq) | 1.64 |
| Book value per share (mrq) | 0.59 |
Cash flow statement
| Operating cash flow (ttm) | -115.87M |
| Levered free cash flow (ttm) | 71.6M |
© 2024 Yahoo. All rights reserved.